Houston Business News - Local Houston News | Houston Business Journal: Houston oncology co. Iterion Therapeutics raises $17M for clinical trials
Iterion Therapeutics is investigating its lead clinical candidate, Tegavivint, in a Phase 1/2a clinical trial in patients with desmoid turmors.
Read More